Vincristine
Brand names,
Vincristine
Analogs
Vincristine
Brand Names Mixture
Vincristine
Chemical_Formula
C46H56N4O10
Vincristine
RX_link
http://www.rxlist.com/cgi/generic3/vincristine.htm
Vincristine
fda sheet
Vincristine
msds (material safety sheet)
Vincristine
Synthesis Reference
No information avaliable
Vincristine
Molecular Weight
824.958 g/mol
Vincristine
Melting Point
220 oC
Vincristine
H2O Solubility
No information avaliable
Vincristine
State
Solid
Vincristine
LogP
4.918
Vincristine
Dosage Forms
Liquid; Solution
Vincristine
Indication
For treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, acute panmyelosis
Vincristine
Pharmacology
Vincristine is a vinca alkaloid antineoplastic agent used as a treatment for various cancers including breast cancer, Hodgkin's disease, Kaposi's sarcoma, and testicular cancer. The vinca alkaloids are structurally similar compounds comprised of 2 multiringed units, vindoline and catharanthine. The vinca alkaloids have become clinically useful since the discovery of their antitumour properties in 1959. Initially, extracts of the periwinkle plant (Catharanthus roseus) were investigated because of putative hypoglycemic properties, but were noted to cause marrow suppression in rats and antileukemic effects in vitro. Vincristine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death. Vincristine has some immunosuppressant effect. The vinca alkaloids are considered to be cell cycle phase-specific.
Vincristine
Absorption
No information avaliable
Vincristine
side effects and Toxicity
IVN-RAT LD50 1300 mg/kg; IPR-MUS LD50 5.2 mg/kg
Vincristine
Patient Information
PATIENT INFORMATION
Follow the links
http://www.rxlist.com/cgi/generic3/vincristine_wcp.htm
http://www.drugs.com/cons/Vincristine.html
Vincristine
Organisms Affected
Humans and other mammals